Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD).
Clinical trial NCT00332241 · COMPLETED
Trial details
- NCT number
- NCT00332241
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2008-04-01
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.